Baker McKenzie advised ATB Therapeutics SA on the deal. ATB Therapeutics SA, a Belgian next-generation antibody company, completed a EUR 54 million Series A financing. The...
Baker McKenzie advised ATB Therapeutics SA on the deal. ATB Therapeutics SA, a Belgian next-generation antibody company, completed a EUR 54 million Series A financing. The...
You must be a Standard 1 Year member to access this content.